Terms: = Gastric cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Treatment
37 results:
1. Characteristic Mutational Damages in gastric and Colorectal Adenocarcinomas.
Yermekova S; Orazgaliyeva M; Goncharova T; Rakhimbekova F; Kaidarova D; Shatkovskaya O
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3939-3947. PubMed ID: 38019254
[TBL] [Abstract] [Full Text] [Related]
2. Helicobacter pylori promotes epithelial-to-mesenchymal transition by downregulating CK2β in gastric cancer cells.
Lee SD; Jeong H; Hwang BR; Yu BM; Cho Y; Nam KT; Kim H; Lee YC
Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166588. PubMed ID: 36404440
[TBL] [Abstract] [Full Text] [Related]
3. Primary gastric dedifferentiated liposarcoma resected endoscopically: A case report.
Cho JH; Byeon JH; Lee SH
World J Gastroenterol; 2022 Jun; 28(23):2625-2632. PubMed ID: 35949354
[TBL] [Abstract] [Full Text] [Related]
4. High Expression of UPK3A Promotes the Progression of gastric cancer Cells by Inactivating p53 Pathway.
Xu D; Guo J; Xu H
Anal Cell Pathol (Amst); 2022; 2022():6897561. PubMed ID: 35774082
[TBL] [Abstract] [Full Text] [Related]
5. ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
El Jabbour T; Misyura M; Cowzer D; Zimmermann M; Rimkunas V; Marra A; Derakhshan F; Selenica P; Parilla M; Setton JS; Ceyhan-Birsoy O; Kemel Y; Catchings A; Ranganathan M; Ku GY; Janjigian YY; Zinda M; Koehler M; Stadler Z; Shia J; Reis-Filho JS; Mandelker D
J Natl Cancer Inst; 2022 May; 114(5):761-770. PubMed ID: 35078243
[TBL] [Abstract] [Full Text] [Related]
6. Down-regulated MicroRNAs in gastric Carcinoma May Be Targets for Therapeutic Intervention and Replacement Therapy.
Weidle UH; Birzele F; Auslaender S; Brinkmann U
Anticancer Res; 2021 Sep; 41(9):4185-4202. PubMed ID: 34475038
[TBL] [Abstract] [Full Text] [Related]
7. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract] [Full Text] [Related]
8. Silencing Ribosomal Protein L22 Promotes Proliferation and Migration, and Inhibits Apoptosis of gastric cancer Cells by Regulating the Murine Double Minute 2-Protein 53 (mdm2-p53) Signaling Pathway.
Sun Z; Qiu Z; Wang Z; Chi H; Shan P
Med Sci Monit; 2021 May; 27():e928375. PubMed ID: 34050122
[TBL] [Abstract] [Full Text] [Related]
9. Chemopreventive Agent 3,3'-Diindolylmethane Inhibits mdm2 in Colorectal cancer Cells.
Gao X; Liu J; Cho KB; Kedika S; Guo B
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629830
[TBL] [Abstract] [Full Text] [Related]
10. Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy.
Li Z; Gao X; Peng X; May Chen MJ; Li Z; Wei B; Wen X; Wei B; Dong Y; Bu Z; Wu A; Wu Q; Tang L; Li Z; Liu Y; Zhang L; Jia S; Zhang L; Shan F; Zhang J; Wu X; Ji X; Ji K; Wu X; Shi J; Xing X; Wu J; Lv G; Shen L; Ji X; Liang H; Ji J
Sci Adv; 2020 Feb; 6(9):eaay4211. PubMed ID: 32133402
[TBL] [Abstract] [Full Text] [Related]
11. Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and mdm2 in colon and gastric cancer cells.
Imanishi M; Yamamoto Y; Wang X; Sugaya A; Hirose M; Endo S; Natori Y; Yamato K; Hyodo I
Cancer Sci; 2019 Feb; 110(2):639-649. PubMed ID: 30488540
[TBL] [Abstract] [Full Text] [Related]
12. Role of screening colonoscopy for colorectal tumors in Helicobacter pylori-related chronic gastritis with mdm2 SNP309 G/G homozygous: A prospective cross-sectional study in Thailand.
Tongtawee T; Simawaranon T; Wattanawongdon W
Turk J Gastroenterol; 2018 Sep; 29(5):555-560. PubMed ID: 30260777
[TBL] [Abstract] [Full Text] [Related]
13. A novel small molecule inhibitor of mdm2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma.
Yi H; Yan X; Luo Q; Yuan L; Li B; Pan W; Zhang L; Chen H; Wang J; Zhang Y; Zhai Y; Qiu MZ; Yang DJ
J Exp Clin Cancer Res; 2018 May; 37(1):97. PubMed ID: 29716622
[TBL] [Abstract] [Full Text] [Related]
14. [D2 radical resection of omental bursa and No.12p and No.8p for gastric carcinoma: a retrospectively analysis from a single center in China].
Chen L; Wei S; Ye Z; Xiao J; Zeng Y; Wang Y; Lin Z; Lin Z; Chen X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):196-200. PubMed ID: 29492920
[TBL] [Abstract] [Full Text] [Related]
15. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.
Ihle MA; Huss S; Jeske W; Hartmann W; Merkelbach-Bruse S; Schildhaus HU; Büttner R; Sihto H; Sundby Hall K; Eriksson M; Reichardt P; Joensuu H; Wardelmann E
PLoS One; 2018; 13(2):e0193048. PubMed ID: 29451912
[TBL] [Abstract] [Full Text] [Related]
16. HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with mdm2 and confers 5-FU resistance by a p53-dependent pathway.
Han Y; Song C; Wang J; Tang H; Peng Z; Lu S
Mol Carcinog; 2018 Jun; 57(6):722-734. PubMed ID: 29436749
[TBL] [Abstract] [Full Text] [Related]
17. CMIP is oncogenic in human gastric cancer cells.
Zhang J; Huang J; Wang X; Chen W; Tang Q; Fang M; Qian Y
Mol Med Rep; 2017 Nov; 16(5):7277-7286. PubMed ID: 28944848
[TBL] [Abstract] [Full Text] [Related]
18. Cisplatin-resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib.
Wang L; Arras J; Katsha A; Hamdan S; Belkhiri A; Ecsedy J; El-Rifai W
Mol Oncol; 2017 Aug; 11(8):981-995. PubMed ID: 28417568
[TBL] [Abstract] [Full Text] [Related]
19. Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathway.
Wang SQ; Wang C; Chang LM; Zhou KR; Wang JW; Ke Y; Yang DX; Shi HG; Wang R; Shi XL; Ma LY; Liu HM
Oncotarget; 2016 Nov; 7(45):72990-73002. PubMed ID: 27659528
[TBL] [Abstract] [Full Text] [Related]
20. Liposarcoma: Multimodality Management and Future Targeted Therapies.
Crago AM; Dickson MA
Surg Oncol Clin N Am; 2016 Oct; 25(4):761-73. PubMed ID: 27591497
[TBL] [Abstract] [Full Text] [Related]
[Next]
